0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Blood Testing Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-19K2113
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Tumor Blood Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Tumor Blood Testing Market Research Report 2025

Code: QYRE-Auto-19K2113
Report
June 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tumor Blood Testing Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Tumor Blood Testing Market

Tumor Blood Testing Market

The global market for Tumor Blood Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Tumor Blood Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Blood Testing.
The Tumor Blood Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Blood Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Blood Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Blood Testing Market Report

Report Metric Details
Report Name Tumor Blood Testing Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Guardant Health, Trovagene, Genomic Health, Roche, Bio-Techne, Pathway Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tumor Blood Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Blood Testing Market report?

Ans: The main players in the Tumor Blood Testing Market are Guardant Health, Trovagene, Genomic Health, Roche, Bio-Techne, Pathway Genomics

What are the Application segmentation covered in the Tumor Blood Testing Market report?

Ans: The Applications covered in the Tumor Blood Testing Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Tumor Blood Testing Market report?

Ans: The Types covered in the Tumor Blood Testing Market report are Blood Protein Testing, Tumor Marker Testing, Others

Recommended Reports

Blood Testing Equipment

Blood Collection Devices

Oncology Testing & Biomarkers

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Blood Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tumor Blood Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Blood Testing Market Perspective (2020-2031)
2.2 Global Tumor Blood Testing Growth Trends by Region
2.2.1 Global Tumor Blood Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Blood Testing Historic Market Size by Region (2020-2025)
2.2.3 Tumor Blood Testing Forecasted Market Size by Region (2026-2031)
2.3 Tumor Blood Testing Market Dynamics
2.3.1 Tumor Blood Testing Industry Trends
2.3.2 Tumor Blood Testing Market Drivers
2.3.3 Tumor Blood Testing Market Challenges
2.3.4 Tumor Blood Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Blood Testing Players by Revenue
3.1.1 Global Top Tumor Blood Testing Players by Revenue (2020-2025)
3.1.2 Global Tumor Blood Testing Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Blood Testing Revenue
3.4 Global Tumor Blood Testing Market Concentration Ratio
3.4.1 Global Tumor Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Blood Testing Revenue in 2024
3.5 Global Key Players of Tumor Blood Testing Head office and Area Served
3.6 Global Key Players of Tumor Blood Testing, Product and Application
3.7 Global Key Players of Tumor Blood Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Blood Testing Breakdown Data by Type
4.1 Global Tumor Blood Testing Historic Market Size by Type (2020-2025)
4.2 Global Tumor Blood Testing Forecasted Market Size by Type (2026-2031)
5 Tumor Blood Testing Breakdown Data by Application
5.1 Global Tumor Blood Testing Historic Market Size by Application (2020-2025)
5.2 Global Tumor Blood Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Blood Testing Market Size (2020-2031)
6.2 North America Tumor Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Blood Testing Market Size by Country (2020-2025)
6.4 North America Tumor Blood Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Blood Testing Market Size (2020-2031)
7.2 Europe Tumor Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Blood Testing Market Size by Country (2020-2025)
7.4 Europe Tumor Blood Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Blood Testing Market Size (2020-2031)
8.2 Asia-Pacific Tumor Blood Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Blood Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Blood Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Blood Testing Market Size (2020-2031)
9.2 Latin America Tumor Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Blood Testing Market Size by Country (2020-2025)
9.4 Latin America Tumor Blood Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Blood Testing Market Size (2020-2031)
10.2 Middle East & Africa Tumor Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Blood Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Blood Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Details
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Tumor Blood Testing Introduction
11.1.4 Guardant Health Revenue in Tumor Blood Testing Business (2020-2025)
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Details
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Tumor Blood Testing Introduction
11.2.4 Trovagene Revenue in Tumor Blood Testing Business (2020-2025)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Tumor Blood Testing Introduction
11.3.4 Genomic Health Revenue in Tumor Blood Testing Business (2020-2025)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Tumor Blood Testing Introduction
11.4.4 Roche Revenue in Tumor Blood Testing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Details
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Tumor Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Tumor Blood Testing Business (2020-2025)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Details
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Tumor Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Tumor Blood Testing Business (2020-2025)
11.6.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Tumor Blood Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blood Protein Testing
 Table 3. Key Players of Tumor Marker Testing
 Table 4. Key Players of Others
 Table 5. Global Tumor Blood Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Tumor Blood Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Tumor Blood Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Tumor Blood Testing Market Share by Region (2020-2025)
 Table 9. Global Tumor Blood Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Tumor Blood Testing Market Share by Region (2026-2031)
 Table 11. Tumor Blood Testing Market Trends
 Table 12. Tumor Blood Testing Market Drivers
 Table 13. Tumor Blood Testing Market Challenges
 Table 14. Tumor Blood Testing Market Restraints
 Table 15. Global Tumor Blood Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Tumor Blood Testing Market Share by Players (2020-2025)
 Table 17. Global Top Tumor Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2024)
 Table 18. Ranking of Global Top Tumor Blood Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Tumor Blood Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Tumor Blood Testing, Headquarters and Area Served
 Table 21. Global Key Players of Tumor Blood Testing, Product and Application
 Table 22. Global Key Players of Tumor Blood Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Tumor Blood Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Tumor Blood Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Tumor Blood Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Tumor Blood Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Tumor Blood Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Tumor Blood Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Tumor Blood Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Tumor Blood Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Tumor Blood Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Tumor Blood Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Tumor Blood Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Tumor Blood Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Tumor Blood Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Tumor Blood Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Tumor Blood Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Tumor Blood Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Tumor Blood Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Tumor Blood Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Tumor Blood Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Guardant Health Company Details
 Table 48. Guardant Health Business Overview
 Table 49. Guardant Health Tumor Blood Testing Product
 Table 50. Guardant Health Revenue in Tumor Blood Testing Business (2020-2025) & (US$ Million)
 Table 51. Guardant Health Recent Development
 Table 52. Trovagene Company Details
 Table 53. Trovagene Business Overview
 Table 54. Trovagene Tumor Blood Testing Product
 Table 55. Trovagene Revenue in Tumor Blood Testing Business (2020-2025) & (US$ Million)
 Table 56. Trovagene Recent Development
 Table 57. Genomic Health Company Details
 Table 58. Genomic Health Business Overview
 Table 59. Genomic Health Tumor Blood Testing Product
 Table 60. Genomic Health Revenue in Tumor Blood Testing Business (2020-2025) & (US$ Million)
 Table 61. Genomic Health Recent Development
 Table 62. Roche Company Details
 Table 63. Roche Business Overview
 Table 64. Roche Tumor Blood Testing Product
 Table 65. Roche Revenue in Tumor Blood Testing Business (2020-2025) & (US$ Million)
 Table 66. Roche Recent Development
 Table 67. Bio-Techne Company Details
 Table 68. Bio-Techne Business Overview
 Table 69. Bio-Techne Tumor Blood Testing Product
 Table 70. Bio-Techne Revenue in Tumor Blood Testing Business (2020-2025) & (US$ Million)
 Table 71. Bio-Techne Recent Development
 Table 72. Pathway Genomics Company Details
 Table 73. Pathway Genomics Business Overview
 Table 74. Pathway Genomics Tumor Blood Testing Product
 Table 75. Pathway Genomics Revenue in Tumor Blood Testing Business (2020-2025) & (US$ Million)
 Table 76. Pathway Genomics Recent Development
 Table 77. Research Programs/Design for This Report
 Table 78. Key Data Information from Secondary Sources
 Table 79. Key Data Information from Primary Sources
 Table 80. Authors List of This Report


List of Figures
 Figure 1. Tumor Blood Testing Picture
 Figure 2. Global Tumor Blood Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumor Blood Testing Market Share by Type: 2024 VS 2031
 Figure 4. Blood Protein Testing Features
 Figure 5. Tumor Marker Testing Features
 Figure 6. Others Features
 Figure 7. Global Tumor Blood Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Tumor Blood Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Ambulatory Surgical Centers Case Studies
 Figure 12. Tumor Blood Testing Report Years Considered
 Figure 13. Global Tumor Blood Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Tumor Blood Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Tumor Blood Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Tumor Blood Testing Market Share by Players in 2024
 Figure 17. Global Top Tumor Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Tumor Blood Testing Revenue in 2024
 Figure 19. North America Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Tumor Blood Testing Market Share by Country (2020-2031)
 Figure 21. United States Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Tumor Blood Testing Market Share by Country (2020-2031)
 Figure 25. Germany Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Tumor Blood Testing Market Share by Region (2020-2031)
 Figure 33. China Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Tumor Blood Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Tumor Blood Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Tumor Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Guardant Health Revenue Growth Rate in Tumor Blood Testing Business (2020-2025)
 Figure 49. Trovagene Revenue Growth Rate in Tumor Blood Testing Business (2020-2025)
 Figure 50. Genomic Health Revenue Growth Rate in Tumor Blood Testing Business (2020-2025)
 Figure 51. Roche Revenue Growth Rate in Tumor Blood Testing Business (2020-2025)
 Figure 52. Bio-Techne Revenue Growth Rate in Tumor Blood Testing Business (2020-2025)
 Figure 53. Pathway Genomics Revenue Growth Rate in Tumor Blood Testing Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS